The Current Status of Allogenic Islet Cell Transplantation

Type 1 Diabetes (T1D) is an autoimmune destruction of pancreatic beta cells. The development of the Edmonton Protocol for islet transplantation in 2000 revolutionized T1D treatment and offered a glimpse at a cure for the disease. In 2022, the 20-year follow-up findings of islet cell transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Zofia, Dadheech, Nidheesh, Razavy, Haide, Pawlick, Rena, Shapiro, A. M. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605704/
https://www.ncbi.nlm.nih.gov/pubmed/37887267
http://dx.doi.org/10.3390/cells12202423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605704/
https://www.ncbi.nlm.nih.gov/pubmed/37887267
http://dx.doi.org/10.3390/cells12202423

Ejemplares similares